Insurance Brokers

Health In Tech

shopify

Conference Minutes

OpenAI

GOOG

GOOGL

SHOP

GGLS

GGLL

FIGS

Below is Dolphin Research's Trans of the FY25 Q4 earnings call for $Shopify (SHOP.US). For the earnings breakdown, see 'Shopify: Solid results yet a plunge — are commerce agents a silver bullet or a poison?'.Core metrics recap, and regional/channel performance are as follows. North America revenue rose 28% YoY, with the platform now covering over 14% of the US e-com market.International revenue grew 36% YoY. Nearly half of merchants are outside North America, and Europe Q4 GMV increased 45% (FXN +35%). Offline: GMV was up 29% YoY...

Alphabet - C

Alphabet

Shopify 

Paymentus

Direxion Daily Googl Bear 1x Shares

Direxion Daily GOOGL Bull 2X Shares

Figs

SHOP (Trans): Under the e-com Agent model, the company still monetizes primarily through payments

Health In Tech released FY2026 Q1 earnings on May 13 After-Market EST, actual revenue USD 8.772 M (forecast USD 7.464 M), actual EPS USD -0.03 (forecast USD -0.02)

Health In Tech to release FY2026 Q1 earnings on May 13 After-Market EST, forecast revenue USD 7.464 M, EPS USD -0.02

Health In Tech released FY2025 earnings on March 25 After-Market EST, actual revenue USD 33.33 M (forecast USD 32.37 M), actual EPS USD 0.02 (forecast USD 0.015)

Health In Tech released FY2025 Q4 earnings on March 25 After-Market EST, actual revenue USD 7.509 M (forecast USD 7.273 M), actual EPS USD -0.01 (forecast USD -0.01)

Health In Tech Completes $7 Million Private Placement Financing

Health In Tech to Release FY2025 Q4 Earnings on March 25, 2026 After-Market EST, Forecast Revenue USD 7.273M, EPS USD -0.01

Health In Tech released FY2025 9 Months earnings on November 12 After-Market (EST), actual revenue USD 25.82 M, actual EPS USD 0.0271

Health In Tech released FY2025 Q3 earnings on November 12 After-Market (EST), actual revenue USD 8.49 M (forecast USD 7.05 M), actual EPS USD 0.008 (forecast USD 0.01)

Health In Tech to release FY2025 Q3 earnings on November 3 After-Market EST, forecast revenue USD 7.271 M, EPS USD 0.005

Health In Tech released FY2025 Q2 earnings on July 21 After-Market EST, actual revenue USD 9.314 M (forecast USD 7.47 M), actual EPS USD 0.01 (forecast USD 0.005)

Health In Tech released FY2025 Semi-Annual earnings on July 21 After-Market EST, actual revenue USD 17.33 M, actual EPS USD 0.0199

Health In Tech to Release FY2025 Q2 Earnings on July 21 After-Market EST, Forecast Revenue USD 7.47 M, EPS USD 0.005

Earnings report released on April 14, 2025 (BJT) with actual revenue of USD 8.015 M and actual EPS of USD 0.0091

Health In Tech to Release FY2025 Q1 Earnings on April 14 After-Market EST, Forecast Revenue USD 6.869 M, EPS USD 0.02

Health In Tech released FY2023 Q4 earnings on March 17, 2025 (EST), with actual revenue of 5.216 M USD and EPS of 0.0148 USD

Health In Tech released FY2024 annual earnings on March 17 After-Market EST, with actual revenue of 19.49 M USD and EPS of 0.01 USD

Health In Tech released FY2024 Q4 earnings on March 17 After-Market (EST), actual revenue 4.905 M USD, actual EPS -0.0084 USD

Health In Tech to Release FY2024 Q4 Earnings on March 17, 2025, After-Market EST

HIT.US released FY2024 Q3 earnings on November 6 (BJT) with actual revenue of 4.459 MUSD and EPS of 0.0072 USD

HIT.US released FY2023 9 Months Earnings on November 6, 2024 (BJT) with actual revenue of 13.94 MUSD and EPS of 0.0288 USD

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Earnings Watch

Health In Tech | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 8.772 M

Health In Tech shares are trading lower after the company reported worse-than-expected Q1 sales results.

benzinga_article

Health In Tech (NASDAQ:HIT) reported Q1 2026 revenue growth of 9% to $8.8 million, but a wider net loss of $1.6 million. The company is increasing investments in sales and technology to capture a larger share of the self-funded health insurance market, where adoption is higher among large businesses. CFO Julia Qian noted total operating expenses rose to $6.7 million, reflecting a strategic shift towards growth initiatives. Health In Tech reiterated its full-year revenue guidance of $45 million to $50 million, indicating potential year-over-year growth of 35% to 50%.

Market Beat

Health In Tech Q1 Earnings Call Highlights

Health In Tech, Inc. (HIT) presented an AI-driven platform aimed at helping small and medium-sized businesses adopt self-funded health plans more easily. The company emphasizes its scalable, fee-based model in a large market, highlighting tools like eDIYBS software for faster quoting and a nationwide provider network. HIT bears no underwriting risk and has received a Buy rating with a $4.00 price target. However, Spark's AI Analyst rates HIT as Neutral due to solid financial health but weak technicals and high P/E valuation. Current market cap stands at $86.76M.

Tip Ranks

Health In Tech Showcases AI Platform in Investor Presentation

Health In Tech | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 8.772 M

XTNT

Xtant Medical Reports First Quarter 2026 Financial Results | XTNT Stock News

StockTitan

Xtant Med

Xtant Medical Reports First Quarter 2026 Financial Results | XTNT Stock News

Health In Tech(HIT.US)

Health In Tech | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 8.772 M

Health In Tech shares are trading lower after the company reported worse-than-expected Q1 sales results.

Health In Tech Q1 Earnings Call Highlights

Health In Tech Showcases AI Platform in Investor Presentation

Health In Tech | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 8.772 M

Xtant Medical Reports First Quarter 2026 Financial Results | XTNT Stock News